BDTXBlack Diamond Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 12380
Ticker: BDTX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-01-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BDTX

Detail

Enriched 2026-08-14 20:47

Market cap: $120,652,868.7
Shares outstanding (class): 57,453,747
Shares outstanding (weighted): 57,453,747
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 21
Location: CAMBRIDGE, MA
Homepage: https://www.blackdiamondtherapeutics.com
Description: Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Market cap and share counts drift.

Funds holding this security

30 funds · 30 positions · $21.91M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$5.64M	0.07%	2,646,444 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$4.54M	0.05%	2,130,050 NS	FIGI
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$2.97M	0.07%	1,396,549 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$2.76M	0.00%	1,297,051 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.06M	0.00%	495,648 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$998.3K	0.02%	468,694 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$692.3K	0.81%	325,000 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$684.9K	0.01%	321,542 NS	FIGI
Small Cap Value Fund Northern Funds	—	$575.8K	0.09%	270,315 NS	FIGI
Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC	—	$429.4K	0.07%	201,600 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$252.4K	0.02%	118,507 NS	FIGI
SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS	—	$198.5K	0.01%	93,180 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$187.4K	0.15%	88,000 NS	FIGI
WisdomTree U.S. SmallCap Fund WisdomTree Trust	EES	$186.1K	0.03%	87,387 NS	FIGI
VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II	—	$183.3K	0.04%	86,058 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERBDTX
FIGI_COMPOSITEBBG00MS4Y0W9
FIGI_SHARE_CLASSBBG00MS4Y0X8
CIK0001701541
ISINUS09203E1055
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a biopharmaceutical firm focused on precision oncology, matching the biological products SIC code.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.